Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
about
The perils of PCR: can we accurately 'correct' antimalarial trials?Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastComparing highly efficacious antimalarial drugs.The effect of varying analytical methods on estimates of anti-malarial clinical efficacy.Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges.Analysing malaria drug trials on a per-individual or per-clone basis: a comparison of methods.
P2860
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@ast
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@en
type
label
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@ast
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@en
prefLabel
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@ast
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@en
P2860
P50
P921
P1433
P1476
Revisiting the design of phase ...... Plasmodium falciparum malaria.
@en
P2093
Win Gutteridge
P2860
P356
10.1371/JOURNAL.PMED.0050227
P407
P577
2008-11-01T00:00:00Z